<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01827007</url>
  </required_header>
  <id_info>
    <org_study_id>HUS469/E6/05</org_study_id>
    <nct_id>NCT01827007</nct_id>
  </id_info>
  <brief_title>Assessment of Fluid Responsiveness by Elevation of PEEP in Patients With Septic Shock</brief_title>
  <official_title>Assessment of Fluid Responsiveness by Elevation of PEEP in Patients With Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate whether fluid responsiveness of the critically ill&#xD;
      patient can be assessed by analysing the PEEP-induced hemodynamic effects to systolic blood&#xD;
      pressure, pulse pressure, aortic blood flow, aortic time-velocity integral and left&#xD;
      ventricular end diastolic area measured with transesophageal echocardiography (PEEP-test).&#xD;
      The chances are compared to increase of CI after volume expansion (gold standard). In&#xD;
      clinical practise, it would be especially relevant if PEEP-induced changes in arterial&#xD;
      pressure variations could be used in evaluation of volume status and fluid responsiveness.&#xD;
      However, as ECHO-derived variables are used in greater extent to guide the treatment with&#xD;
      inappropriate evidence, the simultaneous registration of ECHO-derived hemodynamic&#xD;
      measurements is essential in the study design.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemodynamic changes indicating fluid responsiveness assessed during elevation of PEEP. Change in mean arterial pressure or aortic velocity time integral.</measure>
    <time_frame>Measurement of hemodynamic variables at timepoints 0, 10,20, 60 minutes</time_frame>
    <description>Measurement of hemodynamic variables using a pulmonary catheter and transesophageal echocardiography at baseline PEEP 10, during elevation of PEEP and after volume challenge at PEEP 10 cmH2O</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function and oxygenation</measure>
    <time_frame>0,10,20,60 minutes, at PEEP 10, 20,10 cmH2O and after fluid expansion PEEP10 cmH2O</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>blood gas sample, for assessment of pH, base excess and blood lactate</measure>
    <time_frame>0, 60 min</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Study arm, elevation of PEEP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Volume expansion with gelofusine</intervention_name>
    <arm_group_label>Study arm, elevation of PEEP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:â€¢ Written informed consent by patient or relative&#xD;
&#xD;
          -  Time in ICU &lt; 48 hours&#xD;
&#xD;
          -  Septic shock&#xD;
&#xD;
          -  Pulmonary artery catheter and radial arterial catheter&#xD;
&#xD;
          -  Age 18 - 75 years&#xD;
&#xD;
          -  Sinus rhythm&#xD;
&#xD;
          -  Need for norepinephrine over 0.1 ug/kg/min but otherwise hemodynamically stable i.e no&#xD;
             need to change the dose over the last 15min period before the study&#xD;
&#xD;
          -  Mechanical ventilation with sedation&#xD;
&#xD;
          -  Pwcp &lt;18 mmHg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to elevation of PEEP ( elevated intracranial pressure, pulmonary&#xD;
             hypertension or other contraindication )&#xD;
&#xD;
          -  Contraindication to fluid challenge&#xD;
&#xD;
          -  Contraindication to TEE&#xD;
&#xD;
          -  Previous heart failure, heart valve stenosis of insufficiency&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erika Wilkman, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesia and Intensive Care, Department of Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intensive Care Unit 20, Meilahti Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>HUS</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <study_first_submitted>April 2, 2013</study_first_submitted>
  <study_first_submitted_qc>April 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2013</study_first_posted>
  <last_update_submitted>April 4, 2013</last_update_submitted>
  <last_update_submitted_qc>April 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Erika Wilkman</investigator_full_name>
    <investigator_title>M.D</investigator_title>
  </responsible_party>
  <keyword>norepinephrine infusion</keyword>
  <keyword>under 48 hours in ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polygeline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

